Fig. 4From: Associations of the circulating levels of cytokines with the risk of myeloproliferative neoplasms: a bidirectional mendelian-randomization studyThe GEO dataset analyses the expression of IP10 and IL2ra in each subtype of MPN and their diagnostic value.A: Expression of IP10 and IL2ra in ET and healthy donors; B: ROC curve of the prediction model based on IP10 and IL2ra to distinguish ET from healthy donors; C:IP10 and IL2ra expression in PV and healthy donors; D: ROC curve of the prediction model based on IP10 and IL2ra to distinguish PV from healthy donors; E:IP10 and IL2ra expression in MF and healthy donors; F: ROC curve of the prediction model based on IP10 and IL2ra to distinguish MF from healthy donors; ***P < 0.001, **P < 0.01,*P < 0.05,HC: Healthy donorsBack to article page